News & Insights
December 9, 2021
Agencies Revise Position on Standards-Essential Patents
October 1, 2021
Considering a Move to Texas? Here’s What You Need to Know About Patent Litigation
September 1, 2021
“Purple Book” Patent Listing Under Biological Product Patent Transparency Act: What Is Required, and What to Expect?
June 24, 2021
Supreme Court Decision on Computer Fraud and Abuse Act: Implications for Cybersecurity and Insider Threat Programs
June 7, 2021
Update on the Proposed TRIPS Waiver at the WTO: Where is it Headed, and What to Expect?
June 4, 2021
Tug-of-War: Balancing competing IP interests during energy transition
May 7, 2021
Vanessa Alarcon Duvanel Appointed to the Pool of Arbitrators of the Court of Arbitration for Art
April 7, 2021
“Purple Book” Patent Listing Under Biological Product Patent Transparency Act: What is Required, and What to Expect?
March 4, 2021
Group of Nearly 60 WTO Members Seek Unprecedented Waiver from WTO Intellectual Property Protection for COVID-related Medical Products
February 12, 2021
GSK v. Teva and Induced Infringement by AB-Rated Generics: Where are we now?
February 3, 2021
Challenging Therapeutics IP After Fed. Circ. Drink Can Ruling
January 20, 2021
Digital Health 2021 Russia